Concepedia

Joel R. Gever

JR

Statistics

Publications

26

Citations

1.4K

H-Index

20

Active since

1997

Affiliations

Roche (United States)(Current)

University of California, San Francisco

Institute for Neurodegenerative Disorders

La Roche College

University College London

Joel R. Gever is an author at Roche (United States) specializing in medicine, pharmacology, and biochemistry.

ORCID

Top concepts

Publications per year

1997–2021

26

Publications

26

Pharmacological pleiotropism of the human recombinant <i>α</i><sub>1A</sub>‐adrenoceptor: implications for <i>α</i><sub>1</sub>‐adrenoceptor classification

Anthony Ford, Donald V. Daniels, David J. Chang et al. · British Journal of Pharmacology · 1997 · 219 citations · Full text

, , +14

2-Aminothiazoles as Therapeutic Leads for Prion Diseases

Alejandra Gallardo‐Godoy, Joel R. Gever, Kimberly L. Fife et al. · Journal of Medicinal Chemistry · 2011 · 140 citations

AF‐353, a novel, potent and orally bioavailable P2X3/P2X2/3 receptor antagonist

Joel R. Gever, Rothschild Soto, Robert Henningsen et al. · British Journal of Pharmacology · 2010 · 126 citations · Full text

RO1138452 and RO3244794: characterization of structurally distinct, potent and selective IP (prostacyclin) receptor antagonists

Keith Bley, Anindya Bhattacharya, Don V Daniels et al. · British Journal of Pharmacology · 2005 · 96 citations · Full text

Action of MK‐7264 (gefapixant) at human P2X3 and P2X2/3 receptors and in vivo efficacy in models of sensitisation

David M. Richards, Joel R. Gever, Anthony Ford et al. · British Journal of Pharmacology · 2019 · 88 citations · Full text

Rows per page

1–5 of 26